Important Note

Tufts ended funding for its Open Courseware initiative in 2014. We are now planning to retire this site on June 30, 2018. Content will be available for Tufts contributors after that date. If you have any questions about this please write to

Tufts OpenCourseware
Author: Richard Glickman-Simon, M.D.

Session 4b: Aging and Longevity – Essentials

1. Learning Objectives

By the end of this session, you will be able to:

  • Describe the biology of aging at the molecular, cellular, systemic, and evolutionary levels

  • Distinguish between primary and secondary aging and explain the relevance of each to clinical geriatrics

  • Identify selected biomarkers for longevity and describe how they may be used to manipulate life expectancy or lifespan

  • Differentiate between clinical preventive services as applied to older adults and their younger counterparts

  • Speculate on what accounts for the extreme longevity of the oldest old

2. Readings

  • Westendorp RG. What is healthy aging in the 21st century? American Journal of Clinical Nutrition. 83(2):404S-409S, 2006 Feb.

  • Perls T. Terry D. Understanding the determinants of exceptional longevity. Annals of Internal Medicine. 139(5 Pt 2):445-9, 2003 Sep 2.

3. Additional Resources

  • Armbrecht, HJ. The biology of aging. Journal of Laboratory & Clinical Medicine. 138(4):220-225, October 2001

  • The Biology of Aging. Merck Manual of Geriatrics